Cargando…
Extraordinary Survival Benefits of Severe and Critical Patients with COVID-19 by Immune Modulators: The Outcome of a Clinical Trial in Bangladesh
BACKGROUND: Coronavirus disease (COVID)-19 has devasted the healthcare delivery system as well as social establishments of almost all countries of the world. However, vaccines for containing new cases of COVID-19 are yet to be realized. Also, presently available antiviral drugs and other standard of...
Autores principales: | Islam, Md Azizul, Mazumder, Masudul A, Akhter, Neelima, Huq, AKM Faizul, Al-Mahtab, Mamun, Khan, Md Sakirul I, Akbar, Sheikh MF |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801887/ https://www.ncbi.nlm.nih.gov/pubmed/33511068 http://dx.doi.org/10.5005/jp-journals-10018-1327 |
Ejemplares similares
-
Real-life Management Strategy of COVID-19 Patients in Bangladesh with No Death: An Observational and Cohort Study
por: Faizul Huq, AKM, et al.
Publicado: (2020) -
Treatment of COVID-19 Patients at a Medical College Hospital in Bangladesh
por: Bhuyan, Muhammad AR, et al.
Publicado: (2020) -
High Prevalence of Wilson's Diseases with Low Prevalence of Kayser–Fleischer Rings among Patients with Cryptogenic Chronic Liver Diseases in Bangladesh
por: Choudhury, Nuzhat, et al.
Publicado: (2019) -
Therapeutic Endoscopy during COVID-19 Pandemic: An Observational Study from Bangladesh
por: Al Mahtab, Mamun, et al.
Publicado: (2020) -
Clinical Manifestations of Hospitalized COVID-19 Patients in Bangladesh: A 14-day Observational Study
por: Shaha, Modhusudon, et al.
Publicado: (2021)